Dynavax Announces Publication of Two Papers in Leading Oncology Journal Highlighting Data From Clinical Studies of Its TLR9 Agonist, SD-101

Source :: GlobeNewswire. August 28, 2018
Publication Year :: 2018
Abstract: BERKELEY, Calif., Aug 28, 2018 (GLOBE NEWSWIRE via COMTEX) -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that two peer-reviewed papers reporting clinical studies of SD-101 have been published by [...]

Subjects :: Dynavax Technologies Corp.
Medical research
Medicine, Experimental
Non-Hodgkin's lymphomas
B cells
Clinical trials
Melanoma
Periodical publishing
Pharmaceutical industry
Banking, finance and accounting industries
Business

Tools